The abstract is read at the publisher; the summary is JClub's.
In a multicenter cohort of 1258 adult kidney transplant recipients, initial donor-derived cell-free DNA elevations were linked to 3.7-fold and 6.4-fold higher risks of allograft loss for intermediate and high states.
- Why it matters: Donor-derived cell-free DNA tracks rejection and injury severity, but its relationship to long-term graft outcomes after routine surveillance was not well established.
- What they did: The Kidney Allograft Outcomes AlloSure Registry followed patients who began dd-cfDNA surveillance 15–60 days post-transplant, using a multistate model to classify transitions from low to intermediate (0.5%–1.0%) or high (≥1.0%) dd-cfDNA.
- The result: Transitions from low to intermediate and high dd-cfDNA predicted subsequent allograft loss with adjusted hazard ratios of 3.70 (95% CI, 1.38 to 9.90) and 6.36 (95% CI, 2.80 to 14.42), while mortality did not differ by dd-cfDNA state.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.